nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—Olopatadine—S100A1—ocular cancer	0.307	1	CrCbGaD
Imipramine—HTR1A—Signaling Pathways—E2F1—ocular cancer	0.000223	0.000322	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—E2F1—ocular cancer	0.000222	0.00032	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GNA11—ocular cancer	0.000216	0.000311	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDKN2B—ocular cancer	0.000214	0.000308	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—E2F1—ocular cancer	0.000213	0.000307	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GNA11—ocular cancer	0.00021	0.000304	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN2B—ocular cancer	0.00021	0.000303	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN2B—ocular cancer	0.00021	0.000302	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN2B—ocular cancer	0.000209	0.000301	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN2B—ocular cancer	0.000208	0.000301	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN2B—ocular cancer	0.000206	0.000298	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN2B—ocular cancer	0.000206	0.000297	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—EP300—ocular cancer	0.000205	0.000296	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GNAQ—ocular cancer	0.0002	0.000289	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GNA11—ocular cancer	0.000198	0.000286	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—E2F1—ocular cancer	0.000196	0.000283	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GNAQ—ocular cancer	0.000196	0.000282	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—EP300—ocular cancer	0.000194	0.00028	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—E2F1—ocular cancer	0.000193	0.000278	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—E2F1—ocular cancer	0.000192	0.000278	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—E2F1—ocular cancer	0.000192	0.000277	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—E2F1—ocular cancer	0.000191	0.000276	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—E2F1—ocular cancer	0.000189	0.000273	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—E2F1—ocular cancer	0.000189	0.000272	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GNAQ—ocular cancer	0.000184	0.000266	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MDM2—ocular cancer	0.000182	0.000263	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MDM2—ocular cancer	0.000182	0.000263	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MDM2—ocular cancer	0.000172	0.000248	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—HRAS—ocular cancer	0.000169	0.000244	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—HRAS—ocular cancer	0.000169	0.000244	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GNA11—ocular cancer	0.000168	0.000242	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CDKN1B—ocular cancer	0.000166	0.00024	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CDKN1B—ocular cancer	0.000166	0.00024	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MDM2—ocular cancer	0.000165	0.000238	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—AKT1—ocular cancer	0.000165	0.000237	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—AKT1—ocular cancer	0.000164	0.000237	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000162	0.000233	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—HRAS—ocular cancer	0.00016	0.00023	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CCND1—ocular cancer	0.000159	0.000229	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CCND1—ocular cancer	0.000159	0.000229	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CDKN1B—ocular cancer	0.000157	0.000226	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GNAQ—ocular cancer	0.000156	0.000225	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—AKT1—ocular cancer	0.000155	0.000224	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MDM2—ocular cancer	0.000155	0.000223	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CDKN1A—ocular cancer	0.000154	0.000222	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CDKN1A—ocular cancer	0.000153	0.000221	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—HRAS—ocular cancer	0.000153	0.000221	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CDKN1B—ocular cancer	0.00015	0.000217	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CCND1—ocular cancer	0.00015	0.000216	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—AKT1—ocular cancer	0.000149	0.000216	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—AKT1—ocular cancer	0.000149	0.000215	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—AKT1—ocular cancer	0.000149	0.000215	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—EP300—ocular cancer	0.000146	0.000211	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—EP300—ocular cancer	0.000146	0.000211	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CDKN1A—ocular cancer	0.000145	0.000209	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—HRAS—ocular cancer	0.000144	0.000207	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CCND1—ocular cancer	0.000143	0.000207	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CDKN1B—ocular cancer	0.000141	0.000204	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—AKT1—ocular cancer	0.000141	0.000203	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—AKT1—ocular cancer	0.00014	0.000202	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CDKN1A—ocular cancer	0.000139	0.0002	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—EP300—ocular cancer	0.000138	0.000199	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—AKT1—ocular cancer	0.000135	0.000195	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MDM2—ocular cancer	0.000135	0.000195	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CCND1—ocular cancer	0.000135	0.000195	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MDM2—ocular cancer	0.000134	0.000194	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EP300—ocular cancer	0.000132	0.00019	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CDKN1A—ocular cancer	0.00013	0.000188	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GNA11—ocular cancer	0.00013	0.000187	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—EP300—ocular cancer	0.000129	0.000186	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—EP300—ocular cancer	0.000129	0.000186	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MDM2—ocular cancer	0.000128	0.000185	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MYC—ocular cancer	0.000127	0.000184	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MYC—ocular cancer	0.000127	0.000183	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TGFB1—ocular cancer	0.000127	0.000183	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—AKT1—ocular cancer	0.000127	0.000183	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TGFB1—ocular cancer	0.000127	0.000183	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000126	0.000182	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—HRAS—ocular cancer	0.000125	0.000181	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—HRAS—ocular cancer	0.000125	0.00018	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EP300—ocular cancer	0.000124	0.000179	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—AKT1—ocular cancer	0.000124	0.000179	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	0.000123	0.000178	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	0.000123	0.000177	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	0.000122	0.000176	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	0.000121	0.000175	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000121	0.000174	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MYC—ocular cancer	0.00012	0.000173	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—EP300—ocular cancer	0.00012	0.000173	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TGFB1—ocular cancer	0.00012	0.000173	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	0.000119	0.000172	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MDM2—ocular cancer	0.000118	0.000171	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CCND1—ocular cancer	0.000118	0.00017	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	0.000117	0.000169	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—AKT1—ocular cancer	0.000117	0.000169	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CCND1—ocular cancer	0.000117	0.000169	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MDM2—ocular cancer	0.000117	0.000168	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MDM2—ocular cancer	0.000116	0.000168	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	0.000116	0.000167	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MDM2—ocular cancer	0.000116	0.000167	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MDM2—ocular cancer	0.000116	0.000167	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MYC—ocular cancer	0.000115	0.000166	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TGFB1—ocular cancer	0.000115	0.000166	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MDM2—ocular cancer	0.000114	0.000165	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MDM2—ocular cancer	0.000114	0.000165	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	0.000114	0.000164	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	0.000113	0.000163	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCND1—ocular cancer	0.000112	0.000161	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—EP300—ocular cancer	0.000111	0.00016	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AKT1—ocular cancer	0.000111	0.00016	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AKT1—ocular cancer	0.00011	0.000159	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—HRAS—ocular cancer	0.00011	0.000159	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—HRAS—ocular cancer	0.000108	0.000156	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	0.000108	0.000156	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EP300—ocular cancer	0.000108	0.000156	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MYC—ocular cancer	0.000108	0.000156	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDKN1B—ocular cancer	0.000108	0.000156	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—HRAS—ocular cancer	0.000108	0.000156	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TGFB1—ocular cancer	0.000108	0.000156	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—HRAS—ocular cancer	0.000108	0.000155	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EP300—ocular cancer	0.000108	0.000155	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—HRAS—ocular cancer	0.000107	0.000155	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AKT1—ocular cancer	0.000107	0.000154	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	0.000106	0.000154	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—HRAS—ocular cancer	0.000106	0.000153	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN1B—ocular cancer	0.000106	0.000153	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	0.000106	0.000153	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN1B—ocular cancer	0.000106	0.000153	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN1B—ocular cancer	0.000106	0.000152	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	0.000105	0.000152	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	0.000105	0.000152	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AKT1—ocular cancer	0.000105	0.000152	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AKT1—ocular cancer	0.000105	0.000151	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—ocular cancer	0.000105	0.000151	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN1B—ocular cancer	0.000104	0.000151	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—ocular cancer	0.000104	0.000151	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AKT1—ocular cancer	0.000104	0.000151	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	0.000104	0.00015	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AKT1—ocular cancer	0.000103	0.000149	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCND1—ocular cancer	0.000103	0.000149	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	0.000103	0.000149	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EP300—ocular cancer	0.000103	0.000149	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCND1—ocular cancer	0.000102	0.000146	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCND1—ocular cancer	0.000101	0.000146	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCND1—ocular cancer	0.000101	0.000146	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCND1—ocular cancer	0.000101	0.000145	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—HRAS—ocular cancer	0.0001	0.000144	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—HRAS—ocular cancer	9.99e-05	0.000144	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDKN1A—ocular cancer	9.98e-05	0.000144	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCND1—ocular cancer	9.97e-05	0.000144	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCND1—ocular cancer	9.94e-05	0.000143	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—ocular cancer	9.86e-05	0.000142	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	9.82e-05	0.000142	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN1A—ocular cancer	9.8e-05	0.000141	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN1A—ocular cancer	9.77e-05	0.000141	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN1A—ocular cancer	9.74e-05	0.00014	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—ocular cancer	9.72e-05	0.00014	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN1A—ocular cancer	9.64e-05	0.000139	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	9.62e-05	0.000139	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—ocular cancer	9.56e-05	0.000138	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—ocular cancer	9.54e-05	0.000138	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—EP300—ocular cancer	9.53e-05	0.000138	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—ocular cancer	9.51e-05	0.000137	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EP300—ocular cancer	9.5e-05	0.000137	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—ocular cancer	9.48e-05	0.000137	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—ocular cancer	9.45e-05	0.000136	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HRAS—ocular cancer	9.43e-05	0.000136	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MYC—ocular cancer	9.43e-05	0.000136	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TGFB1—ocular cancer	9.4e-05	0.000136	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—ocular cancer	9.39e-05	0.000135	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MYC—ocular cancer	9.38e-05	0.000135	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	9.36e-05	0.000135	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TGFB1—ocular cancer	9.35e-05	0.000135	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EP300—ocular cancer	9.35e-05	0.000135	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—EP300—ocular cancer	9.34e-05	0.000135	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EP300—ocular cancer	9.32e-05	0.000135	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EP300—ocular cancer	9.29e-05	0.000134	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EP300—ocular cancer	9.27e-05	0.000134	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EP300—ocular cancer	9.18e-05	0.000132	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EP300—ocular cancer	9.15e-05	0.000132	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HRAS—ocular cancer	9.03e-05	0.00013	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MYC—ocular cancer	8.98e-05	0.000129	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	8.95e-05	0.000129	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—ocular cancer	8.88e-05	0.000128	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—ocular cancer	8.83e-05	0.000127	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—ocular cancer	8.82e-05	0.000127	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HRAS—ocular cancer	8.49e-05	0.000123	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—ocular cancer	8.33e-05	0.00012	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MYC—ocular cancer	8.28e-05	0.000119	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TGFB1—ocular cancer	8.26e-05	0.000119	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MYC—ocular cancer	8.14e-05	0.000117	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MYC—ocular cancer	8.13e-05	0.000117	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TGFB1—ocular cancer	8.12e-05	0.000117	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TGFB1—ocular cancer	8.11e-05	0.000117	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MYC—ocular cancer	8.1e-05	0.000117	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TGFB1—ocular cancer	8.08e-05	0.000117	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MYC—ocular cancer	8.07e-05	0.000116	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TGFB1—ocular cancer	8.05e-05	0.000116	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MYC—ocular cancer	8e-05	0.000115	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—ocular cancer	7.98e-05	0.000115	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TGFB1—ocular cancer	7.98e-05	0.000115	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MYC—ocular cancer	7.97e-05	0.000115	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	7.95e-05	0.000115	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—ocular cancer	7.79e-05	0.000112	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—ocular cancer	7.78e-05	0.000112	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—ocular cancer	7.74e-05	0.000112	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—ocular cancer	7.7e-05	0.000111	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—ocular cancer	7.5e-05	0.000108	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HRAS—ocular cancer	7.4e-05	0.000107	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—ocular cancer	7.37e-05	0.000106	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HRAS—ocular cancer	7.37e-05	0.000106	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—ocular cancer	7.25e-05	0.000105	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—EP300—ocular cancer	7.2e-05	0.000104	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HRAS—ocular cancer	7.05e-05	0.000102	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—EP300—ocular cancer	7.03e-05	0.000101	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—ocular cancer	6.8e-05	9.8e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—ocular cancer	6.7e-05	9.66e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—ocular cancer	6.69e-05	9.65e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—ocular cancer	6.67e-05	9.63e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—ocular cancer	6.65e-05	9.6e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—ocular cancer	6.63e-05	9.56e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—EP300—ocular cancer	6.63e-05	9.56e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—ocular cancer	6.57e-05	9.47e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—ocular cancer	6.55e-05	9.45e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—ocular cancer	6.54e-05	9.43e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—ocular cancer	6.5e-05	9.38e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HRAS—ocular cancer	6.5e-05	9.38e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—HRAS—ocular cancer	6.4e-05	9.23e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HRAS—ocular cancer	6.38e-05	9.21e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HRAS—ocular cancer	6.36e-05	9.18e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HRAS—ocular cancer	6.34e-05	9.15e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HRAS—ocular cancer	6.28e-05	9.06e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HRAS—ocular cancer	6.26e-05	9.03e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—ocular cancer	6.23e-05	8.98e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—ocular cancer	5.76e-05	8.31e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—ocular cancer	5.74e-05	8.28e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—ocular cancer	5.65e-05	8.15e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—ocular cancer	5.64e-05	8.14e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—ocular cancer	5.64e-05	8.13e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—ocular cancer	5.62e-05	8.1e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—EP300—ocular cancer	5.61e-05	8.1e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—ocular cancer	5.6e-05	8.08e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—ocular cancer	5.54e-05	8e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—ocular cancer	5.53e-05	7.98e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—ocular cancer	4.35e-05	6.28e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—EP300—ocular cancer	4.33e-05	6.25e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—ocular cancer	4.25e-05	6.13e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—ocular cancer	4e-05	5.78e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—ocular cancer	3.39e-05	4.89e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—ocular cancer	2.62e-05	3.78e-05	CbGpPWpGaD
